[Patient education during outpatient procedures]. / Patientenaufklärung bei ambulanten Eingriffen.

Patient education is a key obligation for doctors under the treatment contract. The expansion of the AOP catalogue (catalogue of operations that can be performed on an outpatient basis in accordance with Section 115b of the Fifth Book of the German Social Code (SGB V)) from January 2023 opens up new outpatient treatment options that tend to involve higher risks. This risk profile must be taken into account when informing patients.In any case, the timing of the information should be chosen so that the patient can give their consent in a well-considered manner. There is no fixed "blocking period" between information and consent, so the patient can consent immediately. In the case of high-risk procedures, the patient should be informed several days in advance. Criteria for determining the right time are the type and severity of the procedure, urgency and individual circumstances of the patient. The information provided should be complete and comprehensible, including the diagnosis, need for treatment, risks and alternatives. Comprehensive documentation of the information provided goes without saying.Telemedical counselling is possible in suitable cases, but the risk of timely and complete counselling remains with the doctor performing the procedure. In view of outpatient procedures that require follow-up care at home, the safety information should be more comprehensive.The expansion of the AOP catalogue opens up new opportunities for outpatient procedures, but harbours legal risks. Adapted risk and safety information is required, whereby telemedicine can optimise practice organisation.

[Patient education during outpatient procedures]. / Patientenaufklärung bei ambulanten Eingriffen.

Patient education is a key obligation for doctors under the treatment contract. The expansion of the AOP catalogue (catalogue of operations that can be performed on an outpatient basis in accordance with Section 115b of the Fifth Book of the German Social Code (SGB V)) from January 2023 opens up new outpatient treatment options that tend to involve higher risks. This risk profile must be taken into account when informing patients.In any case, the timing of the information should be chosen so that the patient can give their consent in a well-considered manner. There is no fixed "blocking period" between information and consent, so the patient can consent immediately. In the case of high-risk procedures, the patient should be informed several days in advance. Criteria for determining the right time are the type and severity of the procedure, urgency and individual circumstances of the patient. The information provided should be complete and comprehensible, including the diagnosis, need for treatment, risks and alternatives. Comprehensive documentation of the information provided goes without saying.Telemedical counselling is possible in suitable cases, but the risk of timely and complete counselling remains with the doctor performing the procedure. In view of outpatient procedures that require follow-up care at home, the safety information should be more comprehensive.The expansion of the AOP catalogue opens up new opportunities for outpatient procedures, but harbours legal risks. Adapted risk and safety information is required, whereby telemedicine can optimise practice organisation.

Evaluation of a Clinical Decision Support System for the most evidence-based approach to managing perioperative anticoagulation.

STUDY OBJECTIVE: We explored the feasibility of a Clinical Decision Support System (CDSS) to guide evidence-based perioperative anticoagulation. DESIGN: Prospective randomised clinical management simulation multicentre study. SETTING: Five University and 11 general hospitals in Germany. PARTICIPANTS: We enrolled physicians (anaesthesiologist (n = 73), trauma surgeons (n = 2), unknown (n = 1)) with different professional experience. INTERVENTIONS: A CDSS based on a multiple-choice test was developed and validated at the University Hospital of Frankfurt (phase-I). The CDSS comprised European guidelines for the management of anticoagulation in cardiology, cardio-thoracic, non-cardio-thoracic surgery and anaesthesiology. Phase-II compared the efficiency of physicians in identifying evidence-based approach of managing perioperative anticoagulation. In total 168 physicians were randomised to CDSS (PERI-KOAG) or CONTROL. MEASUREMENTS: Overall mean score and association of processing time and professional experience were analysed. The multiple-choice test consists of 11 cases and two correct answers per question were required to gain 100% success rate (=22 points). MAIN RESULTS: In total 76 physicians completed the questionnaire (n = 42 PERI-KOAG; n = 34 CONTROL; attrition rate 54%). Overall mean score (max. 100% = 22 points) was significantly higher in PERI-KOAG compared to CONTROL (82 ± 15% vs. 70 ± 10%; 18 ± 3 vs. 15 ± 2 points; P = 0.0003). A longer processing time is associated with significantly increased overall mean scores in PERI-KOAG (≥33 min. 89 ± 10% (20 ± 2 points) vs. <33 min. 73 ± 15% (16 ± 3 points), P = 0.0005) but not in CONTROL (≥33 min. 74 ± 13% (16 ± 3 points) vs. <33 min. 69 ± 9% (15 ± 2 points), P = 0.11). Within PERI-KOAG, there is a tendency towards higher results within the more experienced group (>5 years), but no significant difference to less (≤5 years) experienced colleagues (87 ± 10% (19 ± 2 points) vs. 78 ± 17% (17 ± 4 points), P = 0.08). However, an association between professional experience and success rate in CONTROL has not been shown (71 ± 8% vs. 70 ± 13%, 16 ± 2 vs. 15 ± 3 points; P = 0.66). CONCLUSIONS: CDSS significantly improved the identification of evidence-based treatment approaches. A precise usage of CDSS is mandatory to maximise efficiency.